Teva, Mylan Eye Pfizer's Generic Venture in Brazil

Source: Reuters

Jul 28, 2016

According to Reuter's sources, Teva Pharmaceutical and Mylan have shown early interest in a Brazilian generic drugmaking joint-venture, Laboratório Teut|Pfizer, in which Pfizer has a 40 percent stake.

India's Sun Pharmaceutical and three buyout firms have also expressed interest, said sources.

Brazil's Melo family owns the remaining 60 percent of Teuto|Pfizer, Latin America's largest pharmaceutical plant.

Read the Reuters coverage 

 

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments